港股异动 | 云顶新耀(01952)涨超3% 近期公布mRNA肿瘤疫苗EVM16首次人体数据 公司RNA平台进一步验证

智通财经
May 14

智通财经APP获悉,云顶新耀(01952)涨超3%,截至发稿,涨3.48%,报31.48港元,成交额1.33亿港元。

消息面上,云顶新耀近期宣布,公司在2026年美国癌症研究协会(AACR)年会上公布自研mRNA个性化肿瘤治疗性疫苗EVM16单药治疗及联合PD-1抑制剂(替雷利珠单抗)治疗晚期实体瘤的首次人体临床试验(FIH)数据。

方正证券指出,RNA平台中,现货型TAA mRNA疫苗EVM14实现中美新药临床IND双获批并完成首例患者入组给药;mRNA自体生成CAR-T项目EVM18完成非人灵长类动物概念验证并推进临床开发。自研方面,公司将于2026年上半年公布EVER001(BTK)的1b/2a期详细临床研究数据。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10